Dr. Barry E. Rosenbloom, MD

Expert Publications

• Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.
• Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients.
• Prevalence of type 1 Gaucher disease in the United States.
• Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.
• Multiple myeloma and Gaucher genes.
• Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
• Gaucher disease and comorbidities: B-cell malignancy and parkinsonism.
• Stability is maintained in adults with Gaucher disease type 1 switched from
• Who should treat Hodgkin's disease?
• The deterioration of hemodynamic parameters during thiopental sodium anesthesia.
• Local delayed cutaneous hypersensitivity reactions in breast cancer patients with and without removal of axillary lymph nodes.
• Treatment of pain in sickle-cell crisis.

Media Releases

Get to know Hematologist-Oncologist Dr. Barry E. Rosenbloom, who serves patients in Beverly Hills, California.

Dr. Rosenbloom is a hematologist-oncologist who is currently serving patients at Tower Hematology Oncology Medical Group in  California. Tower Hematology Oncology Medical Group was formed in 1991 as the result of a merger between two well-established medical oncology practices that had served patients in Los Angeles for more than 10 years. “We are a group of diverse cancer specialists that focus on the full spectrum of oncology and hematology problems. By pooling our knowledge, we are able to provide a strong research-based practice to help you receive the most appropriate treatment available” as stated by their website. The mission of Tower Hematology Oncology Medical Group is to provide the highest quality of medical care to patients; offering the most appropriate and current diagnostic and therapeutic modalities in an honest, supportive, respectful and compassionate manner.

The Comprehensive Gaucher Treatment Center at Tower Hematology Oncology in Beverly Hills, under the direction of Dr. Rosenbloom, provides clinical evaluations for the diagnosis and treatment of patients with Gaucher disease. Given the complexity of the disease, the Center utilizes a multi-disciplinary approach to optimize patient care, beginning with genetic testing and counseling. 

Dr. Rosenbloom is a native of New York City. He earned his undergraduate degree from Hunter College, followed by his medical degree from the State University of New York Downstate Medical Center. He then entered the internship and residency training programs at Harbor-University of California, Los Angeles (UCLA), where he became chief resident in medicine. Furthermore, he completed his fellowship in hematology and oncology at Harbor-UCLA.

Dr. Rosenbloom is a former vice-chief and chief of the medical staff at Cedars-Sinai Medical Center. He is also a nationally recognized expert on Gaucher disease and was appointed Clinical Professor of Medicine in 1988 by the UCLA Medical Center. 

Dr. Rosenbloom is board-certified in both internal medicine and medical oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Dr. Rosenbloom has published 66 scientific papers and abstracts in medical journals. He has also directed several drug trials. Dr. Rosenbloom is a Fellow of the American College of Physicians. He is also a member of the Los Angeles County Medical Association, the California Medical Association, the American Medical Association, the American Society of Clinical Oncology, the American Society of Hematology, the American Society of Internal Medicine, and the Jonsson Comprehensive Cancer Center, UCLA.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of disorders related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist, like Dr. Rosenbloom, is a physician who specializes in the diagnosis, treatment, and/or prevention of blood disorders and cancers. His clinical areas of interest include anemias, blood disorders, breast cancer, colorectal cancer, Gaucher’s disease, leukemia, lung cancer, lymphomas, and testicular cancer.

Dr. Rosenbloom and his wife, a senior docent at the Los Angeles County Museum of Art, have two daughters. In his spare time, Dr. Rosenbloom enjoys reading, listening to music, and playing golf.

Recommended Articles

• Genetic Advancements in Lymphoma Treatment

  Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...

• 'Robocop' Stem Cells Developed to Fight Cancer

  Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...

• Schools Join the Fight Against Lymphoma and Blood Cancers

  Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...

• What are the Stages of Multiple Myeloma?

  This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...

• Stanford University's Linebacker Ryan Beecher Must Now Tackle Lymphoma

  There's no doubt that Ryan Beecher is strong. If you want just watch one Stanford University football game, you'll see that and then some. However, he is now going to have to use a different type of strength in his battle against lymphoma.Ryan's storyWhile many had been following Ryan Beecher before...

• Morphos Declared a "Breakthrough Therapy" for Lymphoma

  MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...